Related Experiment Video
Updated: Jun 4, 2026

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
The anti-apoptotic function of human αA-crystallin is directly related to its chaperone activity
N Pasupuleti1, S Matsuyama, O Voss
1Department of Ophthalmology and Visual Sciences, Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.
Abstract:
αA-crystallin is a molecular chaperone and an antiapoptotic protein. This study investigated the mechanism of inhibition of apoptosis by human αA-crystallin and determined if the chaperone activity of αA-crystallin is required for the antiapoptotic function. αA-crystallin inhibited chemical-induced apoptosis in Chinese hamster ovary (CHO) cells and HeLa cells by inhibiting activation of caspase-3 and -9. In CHO cells, it inhibited apoptosis induced by the overexpression of human proapoptotic proteins, Bim and Bax. αA-crystallin inhibited doxorubicin-mediated activation of human procaspase-3 in CHO cells and it activated the PI3K/Akt cell survival pathway by promoting the phosphorylation of PDK1, Akt and phosphatase tensin homologue in HeLa cells. The phosphoinositide 3 kinase (PI3K) activity was increased by αA-crystallin overexpression but the protein content was unaltered. Downregulation of PI3K by the expression of a dominant-negative mutant or inhibition by LY294002 abrogated the ability of αA-crystallin to phosphorylate Akt. These antiapoptotic functions of αA-crystallin were enhanced in a mutant protein (R21A) that shows increased chaperone activity than the wild-type (Wt) protein. Interestingly, a mutant protein (R49A) that shows decreased chaperone activity was far weaker than the Wt protein in its antiapoptotic functions. Together, our study results show that αA-crystallin inhibits apoptosis by enhancing PI3K activity and inactivating phosphatase tensin homologue and that the antiapoptotic function is directly related to its chaperone activity.
Insights
Human alphaA-crystallin (αA-crystallin) prevents cell death by inhibiting apoptosis. Its chaperone activity is essential for this anti-apoptotic function, as shown by studies on cell survival pathways.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- AlphaA-crystallin (αA-crystallin) functions as a molecular chaperone and exhibits antiapoptotic properties.
- Understanding the precise mechanisms by which αA-crystallin inhibits apoptosis is crucial for potential therapeutic applications.
Purpose of the Study:
- To investigate the mechanism of apoptosis inhibition by human αA-crystallin.
- To determine if the chaperone activity of αA-crystallin is essential for its antiapoptotic function.
Main Methods:
- Utilized Chinese hamster ovary (CHO) and HeLa cells to study apoptosis inhibition.
- Assessed the impact of αA-crystallin on caspase activation, proapoptotic protein expression, and the PI3K/Akt cell survival pathway.
- Employed mutant forms of αA-crystallin (R21A and R49A) with varying chaperone activities to correlate function with apoptosis inhibition.
Main Results:
- αA-crystallin inhibited chemical- and proapoptotic protein-induced apoptosis by suppressing caspase-3 and -9 activation.
- Activated the PI3K/Akt pathway by promoting phosphorylation of PDK1, Akt, and phosphatase tensin homologue, while increasing PI3K activity.
- Mutant R21A with enhanced chaperone activity showed improved antiapoptotic effects, whereas mutant R49A with reduced chaperone activity was less effective.
Conclusions:
- αA-crystallin inhibits apoptosis through enhancement of PI3K activity and inactivation of phosphatase tensin homologue.
- The antiapoptotic function of αA-crystallin is directly correlated with its molecular chaperone activity.
More Related Videos
Related Concept Videos
Molecular Chaperones and Protein Folding
The...
Molecular Chaperones and Protein Folding
The...
The Intrinsic Apoptotic Pathway
Aquaporins
Bacterial Protein Maturation
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
